EA201791813A1 - Применение выделенных фракций мастиковой смолы для лечения нейропатии зрительного нерва - Google Patents

Применение выделенных фракций мастиковой смолы для лечения нейропатии зрительного нерва

Info

Publication number
EA201791813A1
EA201791813A1 EA201791813A EA201791813A EA201791813A1 EA 201791813 A1 EA201791813 A1 EA 201791813A1 EA 201791813 A EA201791813 A EA 201791813A EA 201791813 A EA201791813 A EA 201791813A EA 201791813 A1 EA201791813 A1 EA 201791813A1
Authority
EA
Eurasian Patent Office
Prior art keywords
neuropathy
fractions
treatment
distinguished
application
Prior art date
Application number
EA201791813A
Other languages
English (en)
Inventor
Цадик Хазан
Константин Адамский
Андре К.Б. Лукассен
Original Assignee
Регенера Фарма Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Регенера Фарма Лтд. filed Critical Регенера Фарма Лтд.
Publication of EA201791813A1 publication Critical patent/EA201791813A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к терапевтическому применению выделенных фракций мастиковой смолы для лечения нейропатии зрительного нерва. Более конкретно, изобретение относится к способам лечения состояний, связанных с нейропатией зрительного нерва, с применением композиций, содержащих выделенные фракции мастиковой смолы.
EA201791813A 2015-03-08 2016-03-07 Применение выделенных фракций мастиковой смолы для лечения нейропатии зрительного нерва EA201791813A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL237621A IL237621A0 (en) 2015-03-08 2015-03-08 Use of isolated fractions of the gum goddess to treat optic neuropathy
PCT/IL2016/050253 WO2016142936A1 (en) 2015-03-08 2016-03-07 Use of isolated fractions of mastic gum for treating optic neuropathy

Publications (1)

Publication Number Publication Date
EA201791813A1 true EA201791813A1 (ru) 2018-07-31

Family

ID=54070642

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791813A EA201791813A1 (ru) 2015-03-08 2016-03-07 Применение выделенных фракций мастиковой смолы для лечения нейропатии зрительного нерва

Country Status (14)

Country Link
US (1) US11000562B2 (ru)
EP (1) EP3268020A4 (ru)
JP (1) JP6934421B2 (ru)
KR (1) KR20180016336A (ru)
CN (1) CN107405372A (ru)
AU (1) AU2016230720A1 (ru)
BR (1) BR112017019154A2 (ru)
CA (1) CA2978529A1 (ru)
EA (1) EA201791813A1 (ru)
IL (2) IL237621A0 (ru)
MX (1) MX2017011619A (ru)
MY (1) MY191993A (ru)
PH (1) PH12017501601A1 (ru)
WO (1) WO2016142936A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017051422A1 (en) * 2015-09-24 2017-03-30 Regenera Pharma Ltd. Compositions comprising triterpenoids
AU2017322654A1 (en) * 2016-09-08 2019-04-04 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy
EA201990560A1 (ru) 2016-09-08 2019-09-30 Регенера Фарма Лтд. Композиции, содержащие тритерпеноиды, и их применение для лечения оптической нейропатии

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048943B2 (en) 2001-02-13 2006-05-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Carotenoid-loaded liposomes
DE60329098D1 (de) 2002-05-01 2009-10-15 Lavipharm Sa Verwendung von mastix und dessen ätherischen ölen zur verhinderung oder bekämpfung von mikrobieller infektionen
US20050074509A1 (en) 2003-10-02 2005-04-07 Data Medica Padova S.P.A. Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components
WO2005112967A2 (en) 2004-05-19 2005-12-01 Balfour Marketing Corp. Anticancer activity of chios mastic gum
CN105147759A (zh) * 2009-03-04 2015-12-16 瑞吉纳拉制药公司 聚合月桂烯的组合物
PL2403505T3 (pl) * 2009-03-04 2017-06-30 Regenera Pharma Ltd. Terapeutyczne zastosowania frakcji gumy mastyksowej
WO2012032523A2 (en) * 2010-09-07 2012-03-15 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum
WO2013186766A1 (en) 2012-06-11 2013-12-19 Regenera Pharma Ltd. Extracts and therapeutic uses thereof
CN103656290B (zh) 2013-12-11 2015-07-01 张有富 一种治疗视神经萎缩的药物及其制备方法

Also Published As

Publication number Publication date
US20180071351A1 (en) 2018-03-15
PH12017501601A1 (en) 2018-02-12
IL254193A0 (en) 2017-10-31
MY191993A (en) 2022-07-22
CA2978529A1 (en) 2016-09-15
CN107405372A (zh) 2017-11-28
EP3268020A1 (en) 2018-01-17
JP6934421B2 (ja) 2021-09-15
JP2018507873A (ja) 2018-03-22
KR20180016336A (ko) 2018-02-14
WO2016142936A1 (en) 2016-09-15
BR112017019154A2 (pt) 2018-05-02
EP3268020A4 (en) 2018-10-31
MX2017011619A (es) 2018-04-11
US11000562B2 (en) 2021-05-11
IL237621A0 (en) 2015-06-30
AU2016230720A1 (en) 2017-09-07

Similar Documents

Publication Publication Date Title
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
PH12018500714A1 (en) Anti-tigit antigen-binding proteins and methods of use thereof
PH12016501966B1 (en) Compounds and compositions as toll-like receptor 7 agonists
EA201891910A1 (ru) Гетероарильные ингибиторы pad4
EA201692201A1 (ru) Соединения и композиции в качестве агонистов toll-подобного рецептора 7
EA201790806A1 (ru) Иммунорегулирующие средства
BR112017006664A2 (pt) terapias de combinação
EA201691594A1 (ru) Циклопропиламины в качестве ингибиторов lsd1
EA201891251A1 (ru) Бициклические ингибиторы pad4
EA201790273A1 (ru) Флагеллиновые композиции и их применение
MX2019001471A (es) Anticuerpos anti-siglec-7 para el tratamiento del cancer.
NZ720769A (en) Anti-siglec-8 antibodies and methods of use thereof
MX2022000053A (es) Moduladores de interaccion de sestrina-gator2 y sus usos.
EA201691541A1 (ru) Новые анти-baff антитела
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2018009325A (es) Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn).
EA201791096A1 (ru) 4-оксо-3,4-дигидро-1,2,3-бензотриазины в качестве модуляторов gpr139
MX2023010076A (es) Moleculas de union al transcrito 7 similar a inmunoglobulina (ilt7) y metodos de uso de las mismas.
EA201891347A1 (ru) Аза-бензимидазольные ингибиторы pad4
MX2019013808A (es) Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cancer.
PH12017501601A1 (en) Use of isolated fractions of mastic gum for treating optic neuropathy
MX2017003949A (es) Derivados peptidicos novedosos y sus usos.
MX2016010967A (es) Nuevas composiciones para tratar lesiones neuronales mecanicas.